A study found that IGF expression showed a downward trend in MDS-MSCs, suggesting that IGF dysregulation in the bone marrow niche may contribute to ineffective hematopoiesis and disease progression in MDS (139). The gene discussed is IGF1; the disease is myelodysplastic syndrome.